A Trial of Skeletal Targeted Radiotherapy Using Holmium-166-DOTMP in Patients With Multiple Myeloma

This study has been terminated.

( business reasons )

Study NCT00039754 Information provided by Poniard Pharmaceuticals

First Received: June 7, 2002 Last Updated: January 19, 2009 History of Changes

No Study Results Posted for this Study

Study Status:	This study has been terminated.
Estimated Study Completion Date:	No date given
Estimated Primary Completion Date:	No date given